PTC Therapeutics, Inc.
PTCT· Nasdaq
Released Mar 6, 2018, after the close
10-K filed Mar 6, 2018, 65 days after period end · 0001070081-18-000042
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $57.95M | $25.12M | $12.73M | $12.66M |
| Net Income | $1.27M | -$26.80M | -$50.95M | -$27.27M |
| EPS Diluted | $0.03 |
PTC Therapeutics, Inc. · CIK 1070081 · Engraved from SEC EDGAR
| -$0.78 |
| -$1.50 |
| -$0.84 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.